Detail page

Knowledge Web

Person

Fergus J. Couch

Biochemiker

Name	Fergus J. Couch
Place	USA
Academic degree	Dr.
Profession	Biochemiker (characteristic profession)
Related	Mayo Clinic.. Department of Laboratory Medicine Molekulargenetik (Thema) Onkologie (Thema)
Record type	Person
GND-Identifier	1168419115
Record ID	1168419115
Involved in show all Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classification Functional evaluation and clinical classification of BRCA2 variants Germline copy number variants and endometrial cancer risk BRCA-mutated breast cancer: the unmet need, challenges and therapeutic benefits of genetic testing Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancer Publisher Correction: Understanding the genetic complexity of puberty timing across the allele frequency spectrum Understanding the genetic complexity of puberty timing across the allele frequency spectrum Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancer Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY Gene-Environment Interactions Relevant to Estrogen and Risk of Breast Cancer: Can Gene-Environment Interactions Be Detected Only among Candidate SNPs from Genome-Wide Association Studies? Joint association of mammographic density adjusted for age and body mass index and polygenic risk score with breast cancer risk Joint association of mammographic density adjusted for age and body mass index and polygenic risk score with breast cancer risk Comprehensive annotation of BRCA1 and BRCA2 missense variants by functionally validated sequence-based computational prediction models Clinical testing of BRCA1 and BRCA2: a worldwide snapshot of technological practices The PALB2 p.Leu939Trp mutation is not associated with breast cancer risk Patient survival and tumor characteristics associated with CHEK2:p.I157T – findings from the Breast Cancer Association Consortium Novel patient-derived xenograft mouse model for pancreatic acinar cell carcinoma demonstrates single agent activity of oxaliplatin Genes associated with histopathologic features of triple negative breast tumors predict molecular subtypes Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry DNA mismatch repair gene MSH6 implicated in determining age at natural menopause Genetic predisposition to ductal carcinoma in situ of the breast Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer Patient survival and tumor characteristics associated with CHEK2:p.I157T – findings from the Breast Cancer Association Consortium RAD51B in Familial Breast Cancer A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium A comprehensive evaluation of interaction between genetic variants and use of menopausal hormone therapy on mammographic density Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy A comprehensive evaluation of interaction between genetic variants and use of menopausal hormone therapy on mammographic density Candidate locus analysis of the TERT–CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk COMPLEXO: identifying the missing heritability of breast cancer via next generation collaboration Evaluation of chromosome 6p22 as a breast cancer risk modifier locus in a follow-up study of BRCA2 mutation carriers Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers 7q21-rs6964587 and breast cancer risk: an extended case–control study by the Breast Cancer Association Consortium Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study No evidence that GATA3 rs570613 SNP modifies breast cancer risk

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Fergus J. Couch

Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classification

Functional evaluation and clinical classification of BRCA2 variants

Germline copy number variants and endometrial cancer risk

BRCA-mutated breast cancer: the unmet need, challenges and therapeutic benefits of genetic testing

Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancer

Publisher Correction: Understanding the genetic complexity of puberty timing across the allele frequency spectrum

Understanding the genetic complexity of puberty timing across the allele frequency spectrum

Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancer

Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY

Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY

Gene-Environment Interactions Relevant to Estrogen and Risk of Breast Cancer: Can Gene-Environment Interactions Be Detected Only among Candidate SNPs from Genome-Wide Association Studies?

Joint association of mammographic density adjusted for age and body mass index and polygenic risk score with breast cancer risk

Joint association of mammographic density adjusted for age and body mass index and polygenic risk score with breast cancer risk

Comprehensive annotation of BRCA1 and BRCA2 missense variants by functionally validated sequence-based computational prediction models

Clinical testing of BRCA1 and BRCA2: a worldwide snapshot of technological practices

The PALB2 p.Leu939Trp mutation is not associated with breast cancer risk

Patient survival and tumor characteristics associated with CHEK2:p.I157T – findings from the Breast Cancer Association Consortium

Novel patient-derived xenograft mouse model for pancreatic acinar cell carcinoma demonstrates single agent activity of oxaliplatin

Genes associated with histopathologic features of triple negative breast tumors predict molecular subtypes

Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry

DNA mismatch repair gene MSH6 implicated in determining age at natural menopause

Genetic predisposition to ductal carcinoma in situ of the breast

Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk

Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer

Patient survival and tumor characteristics associated with CHEK2:p.I157T – findings from the Breast Cancer Association Consortium

RAD51B in Familial Breast Cancer

A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients

Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium

A comprehensive evaluation of interaction between genetic variants and use of menopausal hormone therapy on mammographic density

Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis

Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy

A comprehensive evaluation of interaction between genetic variants and use of menopausal hormone therapy on mammographic density

Candidate locus analysis of the TERT–CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk

COMPLEXO: identifying the missing heritability of breast cancer via next generation collaboration

Evaluation of chromosome 6p22 as a breast cancer risk modifier locus in a follow-up study of BRCA2 mutation carriers

Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers

7q21-rs6964587 and breast cancer risk: an extended case–control study by the Breast Cancer Association Consortium

Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study

No evidence that GATA3 rs570613 SNP modifies breast cancer risk